市場調查報告書

ECMO (葉克膜/體外式薄膜型人工肺) 系統市場 - 成長,趨勢,預測

Extra Corporeal Membrane Oxygenation (ECMO) System Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 613024
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
ECMO (葉克膜/體外式薄膜型人工肺) 系統市場 - 成長,趨勢,預測 Extra Corporeal Membrane Oxygenation (ECMO) System Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年02月01日內容資訊: 英文 120 Pages
簡介

ECMO(膜外充氧器)系統,通常被稱為葉克膜市場,包括心血管疾病和呼吸道疾病的增加,肺移植的採用率增加,ECMO中心的增加以及為提高人們認識的會議和培訓的開展,技術的進步等都推動了市場的成長此外,在人口稠密的國家(如印度和中國),越來越多的老年人和病人將為ECMO系統提供重要的增長機會。

本報告提供全球ECMO (體外式薄膜型人工肺) 市場調查,提供市場概要,各應用領域·模式·地區的市場趨勢,市場規模的變化與預測,市場佔有率,市場促進·阻礙因素以及市場機會·課題分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
  • 市場阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場細分化

  • 各種模式
    • 靜脈動脈(VA)
    • 靜脈靜脈(VV)
    • 其他
  • 各應用
    • 呼吸疾病
    • 心臟疾病
    • 體外心肺甦醒法(ECPR)
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Alung Technologies Inc.
    • Eurosets
    • Getinge AB
    • Livanova Plc
    • Medtronic
    • Microport Scientific Corporation
    • Nipro Medical Corporation
    • Terumo Medical Corporation
    • Thoratec Corporation
    • Xenios AG

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 51380

The growth of the extracorporeal membrane oxygenation (ECMO) system market can be contributed to the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements. In addition, the rising geriatric population and the number of people suffering from diseases in populous countries such as India & China are factors that are expected to offer significant growth opportunities for ECMO systems.

However, complications associated with extracorporeal membrane oxygenation machine such as bleeding, infections, and technical failures; along with high cost and lack of skilled professionals is a challenge to the market.

Key Market Trends

Respiratory Applications is expected to Dominate the Market

Asthma is one of the major noncommunicable diseases. It is a chronic disease of the air passages of the lungs which inflames and narrows them. According to a World Health Organization 2017 report, there are approximately 235 million people suffering from asthma globally. As per this report, there were 383,000 deaths due to asthma in 2015. Moreover, the prevalence of asthma seems to be increasing at a rapid pace.

As per the Center for Disease Control and Prevention (CDC) 2016 report, the prevalence of asthma among adults aged 20 and over increased from 7.1% in 2009-2010 to 9.2% in 2013-2014. Therefore ECMO is useful as to provide adequate gas exchange and prevent lung injury induced by mechanical ventilation. This is very helpful for asthama patients.

As a result, the use of ECMO in cases of near-fatal asthma (NFA) has increased over the years, as per a report by Hye Ju Yeo et al., published in Critical care Journal 2017. Hence all these factors are expected to help the market growth.

North America is Expected to Dominate the Market

As per the American heart association, coronary heart disease is the leading cause of deaths (45.1%) attributable to the cardiovascular disease in the United States, followed by stroke (16.5 %) and heart failure (8.5 %). Moreover, about 5.7 million adults in the United States die of heart failure every year, of which the percentage of in-hospital failures holds a huge potential to be reduced by the usage of ECMO. COPD is the third-leading cause of death in the United States, with its prevalence increasing in direct correlation with changing demography. Although, non-invasive mechanical ventilation (NIV) is the primary prognosis, a shift has been observed, in recent years, toward ECMO (which is considered to be a more efficient alternative).

According to a recent article published in 2018, the use of extracorporeal membrane oxygenation (ECMO) has been exponentially increasing over the last decade and is now considered as a mainstream lifesaving treatment modality in critical care medicine.

Hence, the survival rates for adults with severe acute respiratory failure treated with ECMO have also improved dramatically over the past 30 years. These factors are expected to help the market grow in the region.

Competitive Landscape

Majority of the extra corporeal membrane oxygenation system are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
    • 4.2.2 Technological Advancements in ECMO Technology
    • 4.2.3 Increased Adoption of ECMO Systems
  • 4.3 Market Restraints
    • 4.3.1 High Cost of ECMO Procedures
    • 4.3.2 Risks Associated with ECMO System
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Modality
    • 5.1.1 Veno-Arterial (VA)
    • 5.1.2 Veno-Venous (VV)
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Respiratory Applications
    • 5.2.2 Cardiac Applications
    • 5.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alung Technologies Inc.
    • 6.1.2 Eurosets
    • 6.1.3 Getinge AB
    • 6.1.4 Livanova Plc
    • 6.1.5 Medtronic
    • 6.1.6 Microport Scientific Corporation
    • 6.1.7 Nipro Medical Corporation
    • 6.1.8 Terumo Medical Corporation
    • 6.1.9 Thoratec Corporation
    • 6.1.10 Xenios AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS